SUDEEPPHRM Share Price | Sudeep Pharma Ltd Stock Analysis & Recommendation

Q: Why is Sudeep Pharma falling/rising?

As of 18-Jan, Sudeep Pharma Ltd's stock price is falling, currently at Rs 585.95, which reflects a decrease of Rs 23.5 or 3.86%. The stock has been underperforming, having lost 5.56% over the last two days, and it has also underperformed its sector by 2.75% today. The stock reached an intraday low of Rs 579.7, indicating significant downward pressure.In terms of trading activity, there has been a notable decline in investor participation, with delivery volume dropping by 57.83% compared to the 5-day average. This reduced interest may contribute to the stock's falling price. Additionally, while the stock's price is higher than its 5-day moving average, it is lower than the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend over a longer period.Overall, the combination of recent price declines, reduced trading volume, and underperformance relative to the sector indicates that Sudeep Pharma's stock is currently facing downward pressure.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

66.46 k (-85.42%) Volume

Shareholding (Dec 2025)

FII

1.67%

Held by 13 FIIs

DII

10.86%

Held by 11 DIIs

Promoter

76.15%

When is the next results date for Sudeep Pharma?

17-Dec-2025

The next results date for Sudeep Pharma is 19 December 2025.

View full answer

Which are the latest news on Sudeep Pharma?

18-Jan-2026

When is the next results date for Sudeep Pharma?

Why is Sudeep Pharma falling/rising?

19-Jan-2026

As of 18-Jan, Sudeep Pharma Ltd's stock price is Rs 585.95, down 3.86%, with significant downward pressure indicated by a recent intraday low and a 57.83% drop in delivery volume. The stock is underperforming its sector and shows a bearish trend relative to longer-term moving averages.

View full answer

Compare Sudeep Pharma with Similar Stocks

Akums Drugs FDC Aarti Pharma

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 6,340 Cr (Mid Cap)

P/E

48.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.10

Return on Equity

19.15%

Price to Book

9.14

Revenue and Profits:

Net Sales:

163 Cr

(Quarterly Results - Sep 2025)

Net Profit:

46 Cr

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Sudeep Pharma?

The next results date for Sudeep Pharma is scheduled for 19 December 2025....

Read full news article

Announcements

General Update

16-Jan-2026 | Source : BSE

Intimation for update in Corporate Identification Number (CIN) and status of the Company on the MCA portal.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Jan-2026 | Source : BSE

Submission of Compliance Certificate Under Reg 74 (5) of SEBI (DP) Regulation 2018 for the Quarter ended 31st December 2025.

Closure of Trading Window

26-Dec-2025 | Source : BSE

Pursuant to the code of conduct on prevention of insider trading of Sudeep Pharma Limited and SEBI (PIT) Regulations 2015 the trading window for dealing in the securities of the company shall be closed for designated persons from Thursday 1st January 2026 and shall remain closed till 48 hours after the declaration of the un-audited financial results of the Company for the quarter ending on 31st December 2025 and other matters if any.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

37.35

Debt to EBITDA (avg)

0.74

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.60

Tax Ratio

24.13%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

19.27%

ROCE (avg)

23.00%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

9.14

EV to EBIT

37.32

EV to EBITDA

35.24

EV to Capital Employed

8.37

EV to Sales

13.33

PEG Ratio

Dividend Yield

ROCE (Latest)

22.44%

ROE (Latest)

19.15%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (5.67%)

FIIs

Held by 13 FIIs (1.67%)

Promoter with highest holding

Riva Resources Private Limited (40.35%)

Highest Public shareholder

Nuvama Crossover Opportunities Fund - Series Iii (3.42%)

Individual Investors Holdings

3.27%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 9.62% vs -24.58% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 18.02% vs -14.43% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "87.88",
          "val2": "80.17",
          "chgp": "9.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.87",
          "val2": "30.39",
          "chgp": "1.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.03",
          "val2": "1.44",
          "chgp": "40.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "29.74",
          "val2": "25.20",
          "chgp": "18.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.13%",
          "val2": "37.91%",
          "chgp": "-2.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.06",
          "val2": "168.40",
          "chgp": "-0.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.27",
          "val2": "60.03",
          "chgp": "2.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.47",
          "val2": "1.99",
          "chgp": "74.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "54.95",
          "val2": "41.98",
          "chgp": "30.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.46%",
          "val2": "35.65%",
          "chgp": "0.81%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "248.57",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "90.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.43",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "67.18",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.38%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "356.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.96",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "4.81",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "95.75",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.99%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

87.88

80.17

9.62%

Operating Profit (PBDIT) excl Other Income

30.87

30.39

1.58%

Interest

2.03

1.44

40.97%

Exceptional Items

0.00

Standalone Net Profit

29.74

25.20

18.02%

Operating Profit Margin (Excl OI)

35.13%

37.91%

-2.78%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 9.62% vs -24.58% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 18.02% vs -14.43% in Jun 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

168.06

168.40

-0.20%

Operating Profit (PBDIT) excl Other Income

61.27

60.03

2.07%

Interest

3.47

1.99

74.37%

Exceptional Items

0.00

Standalone Net Profit

54.95

41.98

30.90%

Operating Profit Margin (Excl OI)

36.46%

35.65%

0.81%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Jun'25

Jun'25

Change(%)

Net Sales

248.57

Operating Profit (PBDIT) excl Other Income

90.42

Interest

3.43

Exceptional Items

0.00

Standalone Net Profit

67.18

Operating Profit Margin (Excl OI)

36.38%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

356.73

Operating Profit (PBDIT) excl Other Income

131.96

Interest

4.81

Exceptional Items

0.00

Standalone Net Profit

95.75

Operating Profit Margin (Excl OI)

36.99%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Sudeep Pharma Ltd

Sudeep Pharma Ltd

Mid Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Sudeep Pharma

1Day

52 Week

CASH

FII

DII

Promoter

When is the next results date for Sudeep Pharma?

Watch in Real-Time

Which are the latest news on Sudeep Pharma?

Why is Sudeep Pharma falling/rising?

Compare Sudeep Pharma with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

When is the next results date for Sudeep Pharma?

Announcements

General Update

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Closure of Trading Window

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Half Yearly Results Snapshot (Standalone) - Sep'25

Nine Monthly Results Snapshot (Standalone) - Jun'25

Annual Results Snapshot (Standalone) - Mar'25

About Sudeep Pharma Ltd

Company Coordinates